Summary:
The Center for Gynecologic ONcology/SalomTangir is conducting a randomized double blind Placebo controlled, Phase 2 study to Assess the Efficacy and Safetyof the study drug in combination with Carboplatin and Paclitaxel or Carboplatin and doxil.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a low Ca 125
•
Had debulking surgery and one line of platinum chemotherapy regimen
relapsed more than 6 months but less than 36 months
Qualified Participants May Receive:
Standard of Care and any study procedures.